Ritchard G Cable1, Donald Brambilla2, Simone A Glynn3, Steven Kleinman4, Alan E Mast5, Bryan R Spencer6, Mars Stone7, Joseph E Kiss8. 1. American Red Cross, Farmington, Connecticut. 2. RTI, Rockville, Maryland. 3. National Heart, Lung, and Blood Institute, Bethesda, Maryland. 4. University of British Columbia, Victoria, British Columbia, Canada. 5. BloodCenter of Wisconsin, Milwaukee, Wisconsin. 6. American Red Cross, Dedham, Massachusetts. 7. Blood Systems Research Institute, San Francisco, California. 8. Institute for Transfusion Medicine, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Understanding the effect of blood donation and iron supplementation on iron balance will inform strategies to manage donor iron status. STUDY DESIGN AND METHODS: A total of 215 donors were randomized to receive ferrous gluconate daily (37.5 mg iron) or no iron for 24 weeks after blood donation. Iron stores were assessed using ferritin and soluble transferrin receptor. Hemoglobin (Hb) iron was calculated from total body Hb. Total body iron (TBI) was estimated by summing iron stores and Hb iron. RESULTS: At 24 weeks, TBI in donors taking iron increased by 281.0 mg (95% confidence interval [CI], 223.4-338.6 mg) compared to before donation, while TBI in donors not on iron decreased by 74.1 mg (95% CI, -112.3 to -35.9; p < 0.0001, iron vs. no iron). TBI increased rapidly after blood donation with iron supplementation, especially in iron-depleted donors. Supplementation increased TBI compared to controls during the first 8 weeks after donation: 367.8 mg (95% CI, 293.5-442.1) versus -24.1 mg (95% CI, -82.5 to 34.3) for donors with a baseline ferritin level of not more than 26 ng/mL and 167.8 mg (95% CI, 116.5-219.2) versus -68.1 mg (95% CI, -136.7 to 0.5) for donors with a baseline ferritin level of more than 26 ng/mL. A total of 88% of the benefit of iron supplementation occurred during the first 8 weeks after blood donation. CONCLUSION: Donors on iron supplementation replaced donated iron while donors not on iron did not. Eight weeks of iron supplementation provided nearly all of the measured improvement in TBI. Daily iron supplementation after blood donation allows blood donors to recover the iron loss from blood donation and prevents sustained iron deficiency.
RCT Entities:
BACKGROUND: Understanding the effect of blood donation and iron supplementation on iron balance will inform strategies to manage donoriron status. STUDY DESIGN AND METHODS: A total of 215 donors were randomized to receive ferrous gluconate daily (37.5 mg iron) or no iron for 24 weeks after blood donation. Iron stores were assessed using ferritin and soluble transferrin receptor. Hemoglobin (Hb) iron was calculated from total body Hb. Total body iron (TBI) was estimated by summing iron stores and Hb iron. RESULTS: At 24 weeks, TBI in donors taking iron increased by 281.0 mg (95% confidence interval [CI], 223.4-338.6 mg) compared to before donation, while TBI in donors not on iron decreased by 74.1 mg (95% CI, -112.3 to -35.9; p < 0.0001, iron vs. no iron). TBI increased rapidly after blood donation with iron supplementation, especially in iron-depleted donors. Supplementation increased TBI compared to controls during the first 8 weeks after donation: 367.8 mg (95% CI, 293.5-442.1) versus -24.1 mg (95% CI, -82.5 to 34.3) for donors with a baseline ferritin level of not more than 26 ng/mL and 167.8 mg (95% CI, 116.5-219.2) versus -68.1 mg (95% CI, -136.7 to 0.5) for donors with a baseline ferritin level of more than 26 ng/mL. A total of 88% of the benefit of iron supplementation occurred during the first 8 weeks after blood donation. CONCLUSION: Donors on iron supplementation replaced donated iron while donors not on iron did not. Eight weeks of iron supplementation provided nearly all of the measured improvement in TBI. Daily iron supplementation after blood donation allows blood donors to recover the iron loss from blood donation and prevents sustained iron deficiency.
Authors: Joseph E Kiss; Donald Brambilla; Simone A Glynn; Alan E Mast; Bryan R Spencer; Mars Stone; Steven H Kleinman; Ritchard G Cable Journal: JAMA Date: 2015-02-10 Impact factor: 56.272
Authors: Christine M Pfeiffer; James D Cook; Zuguo Mei; Mary E Cogswell; Anne C Looker; David A Lacher Journal: Clin Chim Acta Date: 2007-04-24 Impact factor: 3.786
Authors: Zuguo Mei; Mary E Cogswell; Anne C Looker; Christine M Pfeiffer; Sarah E Cusick; David A Lacher; Laurence M Grummer-Strawn Journal: Am J Clin Nutr Date: 2011-03-23 Impact factor: 7.045
Authors: Ritchard G Cable; Simone A Glynn; Joseph E Kiss; Alan E Mast; Whitney R Steele; Edward L Murphy; David J Wright; Ronald A Sacher; Jerry L Gottschall; Leslie H Tobler; Toby L Simon Journal: Transfusion Date: 2011-10-24 Impact factor: 3.157
Authors: Ritchard G Cable; Simone A Glynn; Joseph E Kiss; Alan E Mast; Whitney R Steele; Edward L Murphy; David J Wright; Ronald A Sacher; Jerry L Gottschall; Vibha Vij; Toby L Simon Journal: Transfusion Date: 2010-08-30 Impact factor: 3.157
Authors: Graham A Smith; Sheila A Fisher; Carolyn Doree; Emanuele Di Angelantonio; David J Roberts Journal: Cochrane Database Syst Rev Date: 2014-07-03
Authors: Alan E Mast; John C Langer; Yuelong Guo; Walter Bialkowski; Bryan R Spencer; Tzong-Hae Lee; Joseph Kiss; Ritchard G Cable; Donald Brambilla; Michael P Busch; Grier P Page Journal: Transfusion Date: 2020-03-12 Impact factor: 3.157
Authors: Tamir Kanias; Mars Stone; Grier P Page; Yuelong Guo; Stacy M Endres-Dighe; Marion C Lanteri; Bryan R Spencer; Ritchard G Cable; Darrell J Triulzi; Joseph E Kiss; Edward L Murphy; Steve Kleinman; Mark T Gladwin; Michael P Busch; Alan E Mast Journal: Transfusion Date: 2018-11-26 Impact factor: 3.157
Authors: Eshan U Patel; Jodie L White; Evan M Bloch; Mary K Grabowski; Eric A Gehrie; Parvez M Lokhandwala; Patricia A R Brunker; Ruchika Goel; Beth H Shaz; Paul M Ness; Aaron A R Tobian Journal: Transfusion Date: 2019-02-18 Impact factor: 3.157
Authors: Alan E Mast; Aniko Szabo; Mars Stone; Ritchard G Cable; Bryan R Spencer; Joseph E Kiss Journal: Am J Hematol Date: 2020-04-15 Impact factor: 10.047
Authors: Peter Keller; Roland von Känel; Cesar A Hincapié; Bruno R da Costa; Peter Jüni; Tobias E Erlanger; Nicola Andina; Christoph Niederhauser; Bernhard Lämmle; Stefano Fontana Journal: Sci Rep Date: 2020-08-26 Impact factor: 4.379